Rhinovirus Replication in Human Macrophages Induces NF-κB-Dependent Tumor Necrosis Factor Alpha Production

ABSTRACT Rhinoviruses (RV) are the major cause of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). Rhinoviruses have been shown to activate macrophages, but rhinovirus replication in macrophages has not been reported. Tumor necrosis factor alpha (TNF-α) is implicated in the pathogenesis of acute exacerbations, but its cellular source and mechanisms of induction by virus infection are unclear. We hypothesized that rhinovirus replication in human macrophages causes activation and nuclear translocation of NF-κB, leading to TNF-α production. Using macrophages derived from the human monocytic cell line THP-1 and from primary human monocytes, we demonstrated that rhinovirus replication was productive in THP-1 macrophages, leading to release of infectious virus into supernatants, but was limited in monocyte-derived macrophages, likely due to type I interferon production, which was robust in monocyte-derived but deficient in THP-1-derived macrophages. Similar to bronchial epithelial cells, only small numbers of cells supported complete virus replication. We demonstrated RV-induced activation of NF-κB and colocalization of p65/NF-κB nuclear translocation with virus replication in both macrophage types. The infection induced TNF-α release in a time- and dose-dependent, RV serotype- and receptor-independent manner and was largely (THP-1 derived) or completely (monocyte derived) dependent upon virus replication. Finally, we established the requirement for NF-κB but not p38 mitogen-activated protein kinase in induction of TNF-α. These data suggest RV infection of macrophages may be an important source of proinflammatory cytokines implicated in the pathogenesis of exacerbations of asthma and COPD. They also confirm inhibition of NF-κB as a promising target for development of new therapeutic intervention strategies.

[1]  K. Akagawa Functional Heterogeneity of Colony-Stimulating Factor-Induced Human Nonocyte-Derived Macrophages , 2002, Respirology.

[2]  P. Howarth,et al.  Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. , 2005, Thorax.

[3]  D. Proud,et al.  Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[4]  S. Johnston,et al.  Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus , 2005, The Journal of experimental medicine.

[5]  J. Auwerx,et al.  The human leukemia cell line, THP-1: A multifacetted model for the study of monocyte-macrophage differentiation , 1991, Experientia.

[6]  B. Kirby,et al.  TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis. , 2005, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

[7]  S. Johnston,et al.  PMA induces the MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGF-alpha, Ras/Raf, MEK, ERK and Sp1-dependent mechanisms. , 2004, Journal of molecular biology.

[8]  D. Hommes,et al.  New cytokine therapeutics for inflammatory bowel disease. , 2004, Cytokine.

[9]  J. Gern,et al.  Rhinovirus 3C protease precursors 3CD and 3CD' localize to the nuclei of infected cells. , 2004, The Journal of general virology.

[10]  Shu-Jen Chen,et al.  Selective human enterovirus and rhinovirus inhibitors: An overview of capsid‐binding and protease‐inhibiting molecules , 2004, Medicinal research reviews.

[11]  I. Adcock,et al.  Mitogen-activated protein kinase modulation of nuclear factor-kappaB-induced granulocyte macrophage-colony-stimulating factor release from human alveolar macrophages. , 2004, American journal of respiratory cell and molecular biology.

[12]  S. Johnston,et al.  Host defense function of the airway epithelium in health and disease: clinical background , 2003, Journal of leukocyte biology.

[13]  M. Abe,et al.  Rhinovirus 16 3C Protease Induces Interleukin-8 and Granulocyte-Macrophage Colony-Stimulating Factor Expression in Human Bronchial Epithelial Cells , 2004, Pediatric Research.

[14]  M. Gersten,et al.  Phase II, Randomized, Double-Blind, Placebo-Controlled Studies of Ruprintrivir Nasal Spray 2-Percent Suspension for Prevention and Treatment of Experimentally Induced Rhinovirus Colds in Healthy Volunteers , 2003, Antimicrobial Agents and Chemotherapy.

[15]  V. Imbert,et al.  AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-α in Jurkat leukemic cells , 2003, Oncogene.

[16]  D. Wilkes,et al.  Refractory sarcoidosis responding to infliximab. , 2003, Chest.

[17]  W. Busse,et al.  Double-stranded RNA induces the synthesis of specific chemokines by bronchial epithelial cells. , 2003, American journal of respiratory cell and molecular biology.

[18]  F. Kishi,et al.  Functional heterogeneity of colony‐stimulating factor‐induced human monocyte‐derived macrophages , 2006, International journal of hematology.

[19]  S. Johnston,et al.  Reducing agents inhibit rhinovirus‐induced up‐regulation of the rhinovirus receptor intercellular adhesion molecule‐1 (ICAM‐1) in respiratory epithelial cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[21]  Timothy Ravasi,et al.  The mononuclear phagocyte system revisited , 2002, Journal of leukocyte biology.

[22]  N. Papadopoulos,et al.  Rhinovirus‐induced alterations on peripheral blood mononuclear cell phenotype and costimulatory molecule expression in normal and atopic asthmatic subjects , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[23]  N. Papadopoulos,et al.  A defective type 1 response to rhinovirus in atopic asthma , 2002, Thorax.

[24]  W. Busse,et al.  Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. , 2002, The Journal of infectious diseases.

[25]  R C Read,et al.  Macrophage defences against respiratory tract infections. , 2002, British medical bulletin.

[26]  D. Laskin,et al.  Functional heterogeneity in liver and lung macrophages , 2001, Journal of leukocyte biology.

[27]  P. Thomas Tumour necrosis factor‐α: The role of this multifunctional cytokine in asthma , 2001 .

[28]  M. Yoneyama,et al.  Induction of IRF‐3/‐7 kinase and NF‐κB in response to double‐stranded RNA and virus infection: common and unique pathways , 2001, Genes to cells : devoted to molecular & cellular mechanisms.

[29]  S. Paludan,et al.  Molecular Pathways in Virus-Induced Cytokine Production , 2001, Microbiology and Molecular Biology Reviews.

[30]  K. Wright,et al.  Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[31]  P. Thomas Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma. , 2001, Immunology and cell biology.

[32]  V. Casolaro,et al.  Role of NF-κB in Cytokine Production Induced from Human Airway Epithelial Cells by Rhinovirus Infection1 , 2000, The Journal of Immunology.

[33]  R. Panettieri,et al.  Activation of tumor necrosis factor receptor 1 in airway smooth muscle: a potential pathway that modulates bronchial hyper-responsiveness in asthma? , 2000, Respiratory research.

[34]  P. Dragovich,et al.  Inhibition of Human Rhinovirus-Induced Cytokine Production by AG7088, a Human Rhinovirus 3C Protease Inhibitor , 2000, Antimicrobial Agents and Chemotherapy.

[35]  V. Casolaro,et al.  Role of NF-kB in Cytokine Production Induced from Human Airway Epithelial Cells by Rhinovirus Infection , 2000 .

[36]  Joan Wilson,et al.  Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[37]  S. Amar,et al.  Differentiation of Monocytes to Macrophages Primes Cells for Lipopolysaccharide Stimulation via Accumulation of Cytoplasmic Nuclear Factor κB , 1999, Infection and Immunity.

[38]  S. Johnston,et al.  Respiratory Epithelial Cell Expression of Vascular Cell Adhesion Molecule-1 and Its Up-regulation by Rhinovirus Infection via NF-κB and GATA Transcription Factors* , 1999, The Journal of Biological Chemistry.

[39]  O. Majdic,et al.  Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10. , 1999, The Journal of clinical investigation.

[40]  P. Hart,et al.  Differential responses of human monocytes and macrophages to IL‐4 and IL‐13 , 1999, Journal of leukocyte biology.

[41]  M. Kurimoto,et al.  Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. , 1999, Journal of immunology.

[42]  M. Schroth,et al.  Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. , 1999, American journal of respiratory cell and molecular biology.

[43]  S. Johnston,et al.  Rhinovirus Infection Induces Expression of Its Own Receptor Intercellular Adhesion Molecule 1 (ICAM-1) via Increased NF-κB-mediated Transcription* , 1999, The Journal of Biological Chemistry.

[44]  J. Gliemann,et al.  Receptors of the low density lipoprotein (LDL) receptor family in man. Multiple functions of the large family members via interaction with complex ligands. , 1998, Biological chemistry.

[45]  S. Johnston,et al.  Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium. , 1998, Journal of immunology.

[46]  M. Yamaya,et al.  Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1β. , 1997, American journal of physiology. Lung cellular and molecular physiology.

[47]  S. Johnston,et al.  Rhinoviruses induce interleukin-8 mRNA and protein production in human monocytes. , 1997, The Journal of infectious diseases.

[48]  B. Aggarwal,et al.  Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[49]  W. Busse,et al.  Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism. , 1996, Journal of immunology.

[50]  P. Barnes,et al.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.

[51]  Weiliang Tang,et al.  Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. , 1996, The Journal of clinical investigation.

[52]  W. Busse,et al.  Rhinovirus enters but does not replicate inside monocytes and airway macrophages. , 1996, Journal of immunology.

[53]  R. Maini,et al.  Anti-cytokine therapy in rheumatoid arthritis. , 1995, Bailliere's clinical rheumatology.

[54]  R. Silverman,et al.  Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity. , 1995, The Journal of clinical investigation.

[55]  Stephen T Holgate,et al.  Community study of role of viral infections in exacerbations of asthma in 9-11 year old children , 1995, BMJ.

[56]  F. Hayden,et al.  Localization of human rhinovirus replication in the upper respiratory tract by in situ hybridization. , 1995, The Journal of infectious diseases.

[57]  W. Busse,et al.  A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. , 1994, The Journal of clinical investigation.

[58]  S. Johnston,et al.  Detection of rhinovirus infection of the nasal mucosa by oligonucleotide in situ hybridization. , 1994, American journal of respiratory cell and molecular biology.

[59]  K. Nicholson,et al.  Respiratory viruses and exacerbations of asthma in adults. , 1993, BMJ.

[60]  A. Villani,et al.  Restricted replication of respiratory syncytial virus in human alveolar macrophages. , 1993, The Journal of general virology.

[61]  K. Tracey,et al.  Tumor necrosis factor, other cytokines and disease. , 1993, Annual review of cell biology.

[62]  S. Mohla,et al.  Phorbol myristate acetate-differentiated THP-1 cells display increased levels of MHC class I and class II mRNA and interferon-gamma-inducible tumoricidal activity. , 1993, Oncology research.

[63]  R. Furth Production and migration of monocytes and kinetics of macrophages , 1992 .

[64]  C. Jongeneel,et al.  Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-alpha promoter in primary macrophages. , 1991, Journal of immunology.

[65]  D. Gemsa,et al.  Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides. , 1990, Journal of immunology.

[66]  C V Jongeneel,et al.  Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages , 1990, The Journal of experimental medicine.

[67]  M. Auger Mononuclear phagocytes. , 1989, BMJ.

[68]  K. Tada,et al.  Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. , 1982, Cancer research.

[69]  C. Mims,et al.  Influenza virus replication in human alveolar macrophages , 1982, Journal of medical virology.